Concepts (245)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Tongue | 2 | 2018 | 132 | 1.30 | Why? |
| Sialadenitis | 4 | 2018 | 31 | 1.20 | Why? |
| Otorhinolaryngologic Diseases | 2 | 2020 | 491 | 0.98 | Why? |
| Parotitis | 2 | 2020 | 38 | 0.92 | Why? |
| Sleep Apnea, Obstructive | 3 | 2018 | 668 | 0.88 | Why? |
| Endoscopy | 9 | 2021 | 1564 | 0.85 | Why? |
| Otitis Media | 2 | 2020 | 106 | 0.84 | Why? |
| Hyaluronic Acid | 2 | 2018 | 168 | 0.79 | Why? |
| Hyoid Bone | 1 | 2018 | 4 | 0.79 | Why? |
| Voice Disorders | 1 | 2020 | 90 | 0.77 | Why? |
| Salivary Gland Calculi | 2 | 2018 | 8 | 0.75 | Why? |
| Nasopharyngitis | 1 | 2018 | 16 | 0.74 | Why? |
| Palate, Soft | 1 | 2017 | 11 | 0.72 | Why? |
| Salivary Ducts | 1 | 2017 | 19 | 0.71 | Why? |
| Submandibular Gland | 1 | 2017 | 29 | 0.69 | Why? |
| Lymphadenitis | 1 | 2018 | 53 | 0.69 | Why? |
| Snoring | 1 | 2017 | 70 | 0.69 | Why? |
| Salivary Gland Diseases | 1 | 2017 | 17 | 0.69 | Why? |
| Granuloma, Pyogenic | 1 | 2016 | 11 | 0.68 | Why? |
| Ear Diseases | 1 | 2018 | 58 | 0.68 | Why? |
| Tongue Diseases | 1 | 2016 | 41 | 0.65 | Why? |
| Therapeutic Irrigation | 1 | 2018 | 167 | 0.64 | Why? |
| Oral Surgical Procedures | 1 | 2016 | 60 | 0.61 | Why? |
| Natural Orifice Endoscopic Surgery | 1 | 2017 | 127 | 0.59 | Why? |
| Mycobacterium Infections, Nontuberculous | 1 | 2018 | 167 | 0.58 | Why? |
| Sinusitis | 3 | 2018 | 649 | 0.56 | Why? |
| Sjogren's Syndrome | 1 | 2017 | 284 | 0.53 | Why? |
| Rhinitis | 2 | 2018 | 626 | 0.52 | Why? |
| Salivary Calculi | 2 | 2018 | 4 | 0.37 | Why? |
| Head and Neck Neoplasms | 2 | 2018 | 1568 | 0.37 | Why? |
| Reconstructive Surgical Procedures | 1 | 2018 | 860 | 0.37 | Why? |
| Adjuvants, Immunologic | 1 | 2018 | 1709 | 0.35 | Why? |
| Vocal Cords | 2 | 2017 | 35 | 0.34 | Why? |
| Lithotripsy | 2 | 2017 | 48 | 0.33 | Why? |
| Dysphonia | 2 | 2017 | 93 | 0.32 | Why? |
| Otolaryngology | 1 | 2020 | 1917 | 0.30 | Why? |
| Pregnancy Complications | 1 | 2016 | 1388 | 0.29 | Why? |
| Patient Care Team | 1 | 2018 | 3556 | 0.27 | Why? |
| Oropharynx | 2 | 2020 | 1581 | 0.23 | Why? |
| Glucocorticoids | 1 | 2017 | 4431 | 0.22 | Why? |
| Laryngostenosis | 1 | 2021 | 48 | 0.22 | Why? |
| Physicians | 1 | 2020 | 4214 | 0.21 | Why? |
| Tracheal Stenosis | 1 | 2021 | 80 | 0.21 | Why? |
| Laryngeal Diseases | 1 | 2020 | 60 | 0.20 | Why? |
| Pharynx | 2 | 2017 | 1544 | 0.20 | Why? |
| Eikenella | 1 | 2018 | 3 | 0.20 | Why? |
| Voice Quality | 2 | 2017 | 92 | 0.20 | Why? |
| Recurrence | 3 | 2018 | 3675 | 0.19 | Why? |
| Fusobacterium | 1 | 2018 | 19 | 0.19 | Why? |
| Sclerotherapy | 1 | 2018 | 23 | 0.19 | Why? |
| Streptococcus | 1 | 2018 | 76 | 0.19 | Why? |
| Signaling Lymphocytic Activation Molecule Associated Protein | 1 | 2017 | 4 | 0.18 | Why? |
| Lymphangioma, Cystic | 1 | 2017 | 6 | 0.18 | Why? |
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2017 | 65 | 0.18 | Why? |
| Myringosclerosis | 1 | 2017 | 2 | 0.18 | Why? |
| Voice Training | 1 | 2017 | 11 | 0.18 | Why? |
| Speech Production Measurement | 1 | 2017 | 10 | 0.17 | Why? |
| Salivary Duct Calculi | 1 | 2016 | 2 | 0.17 | Why? |
| Sella Turcica | 1 | 2017 | 9 | 0.17 | Why? |
| CD40 Ligand | 1 | 2017 | 121 | 0.17 | Why? |
| Hearing Loss, Conductive | 1 | 2017 | 13 | 0.17 | Why? |
| Kartagener Syndrome | 1 | 2017 | 19 | 0.17 | Why? |
| Hearing Loss, Sudden | 1 | 2019 | 103 | 0.17 | Why? |
| Neuronavigation | 1 | 2017 | 12 | 0.17 | Why? |
| Mucociliary Clearance | 1 | 2018 | 72 | 0.17 | Why? |
| Neoplasms, Unknown Primary | 1 | 2016 | 28 | 0.17 | Why? |
| Models, Anatomic | 1 | 2018 | 191 | 0.17 | Why? |
| Sphenoid Sinus | 1 | 2017 | 26 | 0.17 | Why? |
| Nasal Surgical Procedures | 1 | 2018 | 102 | 0.17 | Why? |
| Hearing Loss, Sensorineural | 1 | 2019 | 159 | 0.17 | Why? |
| Treatment Outcome | 10 | 2021 | 51732 | 0.17 | Why? |
| Antibiotics, Antineoplastic | 1 | 2017 | 128 | 0.16 | Why? |
| Otitis Media with Effusion | 1 | 2017 | 39 | 0.16 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.16 | Why? |
| Meningioma | 1 | 2017 | 37 | 0.16 | Why? |
| Pituitary Diseases | 1 | 2017 | 38 | 0.16 | Why? |
| Nontuberculous Mycobacteria | 1 | 2018 | 114 | 0.16 | Why? |
| Speech Acoustics | 1 | 2017 | 77 | 0.16 | Why? |
| Iodine Radioisotopes | 1 | 2017 | 124 | 0.16 | Why? |
| Disability Evaluation | 2 | 2017 | 671 | 0.16 | Why? |
| Magnetic Resonance Imaging | 5 | 2019 | 6551 | 0.16 | Why? |
| Acoustics | 1 | 2017 | 130 | 0.16 | Why? |
| Head | 1 | 2018 | 206 | 0.15 | Why? |
| Polysomnography | 1 | 2017 | 296 | 0.15 | Why? |
| Prenatal Diagnosis | 1 | 2018 | 345 | 0.15 | Why? |
| Sirolimus | 1 | 2017 | 240 | 0.15 | Why? |
| Biofilms | 1 | 2018 | 304 | 0.15 | Why? |
| Neck | 1 | 2018 | 307 | 0.15 | Why? |
| Pilot Projects | 2 | 2017 | 5182 | 0.15 | Why? |
| Dissection | 1 | 2016 | 164 | 0.14 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.14 | Why? |
| Chronic Disease | 4 | 2018 | 5139 | 0.14 | Why? |
| Group Processes | 1 | 2017 | 210 | 0.14 | Why? |
| Nasal Polyps | 1 | 2018 | 221 | 0.14 | Why? |
| Cadaver | 1 | 2018 | 626 | 0.14 | Why? |
| Apigenin | 1 | 2013 | 14 | 0.14 | Why? |
| Skull Base | 1 | 2017 | 246 | 0.14 | Why? |
| T-Lymphocytes, Helper-Inducer | 1 | 2017 | 497 | 0.13 | Why? |
| Saliva | 2 | 2020 | 4679 | 0.13 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.13 | Why? |
| Tongue Neoplasms | 1 | 2013 | 54 | 0.13 | Why? |
| Humans | 39 | 2021 | 930598 | 0.13 | Why? |
| Pharyngitis | 1 | 2018 | 687 | 0.13 | Why? |
| Child | 7 | 2020 | 70012 | 0.13 | Why? |
| Administration, Intranasal | 1 | 2018 | 1132 | 0.13 | Why? |
| Cell Cycle Checkpoints | 1 | 2013 | 126 | 0.13 | Why? |
| Keratinocytes | 1 | 2013 | 119 | 0.12 | Why? |
| Specimen Handling | 2 | 2020 | 6190 | 0.12 | Why? |
| Adipose Tissue | 1 | 2017 | 612 | 0.12 | Why? |
| Mouth | 1 | 2017 | 622 | 0.12 | Why? |
| Tracheostomy | 3 | 2021 | 1963 | 0.11 | Why? |
| Neoplasm Recurrence, Local | 1 | 2018 | 1063 | 0.11 | Why? |
| Nasopharynx | 2 | 2020 | 10224 | 0.11 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.11 | Why? |
| Pandemics | 7 | 2020 | 389249 | 0.10 | Why? |
| Delivery, Obstetric | 1 | 2018 | 1292 | 0.09 | Why? |
| Enzyme Inhibitors | 1 | 2020 | 1881 | 0.09 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.09 | Why? |
| Microbiota | 1 | 2018 | 1240 | 0.09 | Why? |
| Female | 18 | 2021 | 380317 | 0.09 | Why? |
| Equipment Design | 1 | 2018 | 3095 | 0.08 | Why? |
| Diagnosis, Differential | 2 | 2018 | 7220 | 0.08 | Why? |
| Male | 17 | 2021 | 367725 | 0.08 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.08 | Why? |
| Amphotericin B | 1 | 2007 | 256 | 0.08 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.08 | Why? |
| Drug Discovery | 1 | 2020 | 3092 | 0.07 | Why? |
| Pregnancy | 2 | 2018 | 23879 | 0.07 | Why? |
| Longitudinal Studies | 2 | 2017 | 9893 | 0.07 | Why? |
| Carcinoma, Squamous Cell | 1 | 2013 | 902 | 0.07 | Why? |
| MicroRNAs | 1 | 2017 | 1787 | 0.07 | Why? |
| Evidence-Based Medicine | 1 | 2018 | 3228 | 0.07 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.07 | Why? |
| Aspergillosis | 1 | 2007 | 264 | 0.07 | Why? |
| Pregnancy Outcome | 1 | 2016 | 3803 | 0.06 | Why? |
| Adult | 12 | 2021 | 244371 | 0.06 | Why? |
| Apoptosis | 1 | 2013 | 2335 | 0.06 | Why? |
| Video Recording | 2 | 2020 | 786 | 0.06 | Why? |
| B-Lymphocytes | 1 | 2017 | 4418 | 0.06 | Why? |
| Follow-Up Studies | 2 | 2020 | 17020 | 0.06 | Why? |
| Child, Preschool | 4 | 2021 | 36283 | 0.06 | Why? |
| Aerosols | 1 | 2018 | 5393 | 0.06 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.05 | Why? |
| Virus Internalization | 1 | 2020 | 7921 | 0.05 | Why? |
| Italy | 3 | 2020 | 38444 | 0.05 | Why? |
| Tracheal Diseases | 1 | 2020 | 37 | 0.05 | Why? |
| Aged | 10 | 2021 | 215776 | 0.05 | Why? |
| Infant, Newborn | 2 | 2018 | 23105 | 0.05 | Why? |
| Health Personnel | 2 | 2020 | 29646 | 0.05 | Why? |
| Catheterization | 1 | 2021 | 264 | 0.05 | Why? |
| Respiratory Insufficiency | 1 | 2020 | 7301 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.05 | Why? |
| Stapedius | 1 | 2017 | 2 | 0.04 | Why? |
| Acoustic Impedance Tests | 1 | 2017 | 16 | 0.04 | Why? |
| Reflex | 1 | 2017 | 22 | 0.04 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.04 | Why? |
| Otoacoustic Emissions, Spontaneous | 1 | 2017 | 46 | 0.04 | Why? |
| Audiometry, Pure-Tone | 1 | 2017 | 64 | 0.04 | Why? |
| Phonation | 1 | 2017 | 49 | 0.04 | Why? |
| Time Factors | 2 | 2017 | 31397 | 0.04 | Why? |
| Antifungal Agents | 1 | 2007 | 1828 | 0.04 | Why? |
| Neck Dissection | 1 | 2016 | 109 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Primary Cell Culture | 1 | 2017 | 501 | 0.04 | Why? |
| Tonsillectomy | 1 | 2016 | 115 | 0.04 | Why? |
| Paranasal Sinuses | 1 | 2018 | 217 | 0.04 | Why? |
| Middle Aged | 10 | 2019 | 270681 | 0.04 | Why? |
| Pituitary Neoplasms | 1 | 2017 | 130 | 0.04 | Why? |
| Germinal Center | 1 | 2017 | 332 | 0.03 | Why? |
| Aged, 80 and over | 4 | 2017 | 88759 | 0.03 | Why? |
| Adolescent | 4 | 2018 | 86841 | 0.03 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.03 | Why? |
| Granulomatosis with Polyangiitis | 1 | 2017 | 161 | 0.03 | Why? |
| Lymphatic Metastasis | 1 | 2016 | 537 | 0.03 | Why? |
| Infant | 1 | 2017 | 30274 | 0.03 | Why? |
| Promoter Regions, Genetic | 1 | 2017 | 823 | 0.03 | Why? |
| Species Specificity | 1 | 2017 | 1356 | 0.03 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.03 | Why? |
| Acute Disease | 2 | 2020 | 6029 | 0.03 | Why? |
| Gene Regulatory Networks | 1 | 2017 | 820 | 0.03 | Why? |
| Young Adult | 3 | 2017 | 93724 | 0.03 | Why? |
| Cell Differentiation | 1 | 2017 | 1338 | 0.03 | Why? |
| Cell Cycle Proteins | 1 | 2013 | 297 | 0.03 | Why? |
| Positron-Emission Tomography | 1 | 2016 | 802 | 0.03 | Why? |
| Blotting, Western | 1 | 2013 | 863 | 0.03 | Why? |
| Airway Management | 1 | 2020 | 1298 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.03 | Why? |
| Administration, Oral | 1 | 2017 | 2340 | 0.03 | Why? |
| In Vitro Techniques | 1 | 2013 | 1027 | 0.02 | Why? |
| Lymph Nodes | 1 | 2016 | 1060 | 0.02 | Why? |
| Severity of Illness Index | 1 | 2017 | 48226 | 0.02 | Why? |
| Prospective Studies | 3 | 2019 | 43301 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2016 | 3395 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2021 | 3755 | 0.02 | Why? |
| Leukemia, Myeloid | 1 | 2007 | 76 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Recovery of Function | 1 | 2017 | 2461 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2017 | 3788 | 0.02 | Why? |
| Cell Proliferation | 1 | 2013 | 1973 | 0.02 | Why? |
| Adaptive Immunity | 1 | 2017 | 2585 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2017 | 4020 | 0.02 | Why? |
| Intubation, Intratracheal | 1 | 2020 | 3962 | 0.02 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.02 | Why? |
| Tertiary Care Centers | 1 | 2021 | 8248 | 0.02 | Why? |
| Postoperative Complications | 1 | 2021 | 5861 | 0.02 | Why? |
| Myeloproliferative Disorders | 1 | 2007 | 507 | 0.02 | Why? |
| Databases, Factual | 1 | 2018 | 6248 | 0.02 | Why? |
| Cells, Cultured | 1 | 2013 | 5835 | 0.01 | Why? |
| Stem Cell Transplantation | 1 | 2007 | 531 | 0.01 | Why? |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2007 | 526 | 0.01 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.01 | Why? |
| Protein Binding | 1 | 2017 | 11430 | 0.01 | Why? |
| Signal Transduction | 1 | 2017 | 7207 | 0.01 | Why? |
| Antineoplastic Agents | 1 | 2016 | 3550 | 0.01 | Why? |
| Length of Stay | 1 | 2017 | 11042 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2020 | 22971 | 0.01 | Why? |
| Health Behavior | 1 | 2017 | 4449 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Mice | 1 | 2017 | 21357 | 0.01 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 1573 | 0.01 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2019 | 14232 | 0.01 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 8811 | 0.01 | Why? |
| Prognosis | 1 | 2016 | 32490 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2017 | 25144 | 0.01 | Why? |
| Immunocompromised Host | 1 | 2007 | 5150 | 0.01 | Why? |
| Risk Factors | 1 | 2018 | 71621 | 0.01 | Why? |
| Animals | 1 | 2017 | 78931 | 0.01 | Why? |
| Splenomegaly | 1 | 1964 | 43 | 0.00 | Why? |
| Mucoproteins | 1 | 1964 | 32 | 0.00 | Why? |
| Orosomucoid | 1 | 1964 | 60 | 0.00 | Why? |
| Cholelithiasis | 1 | 1964 | 47 | 0.00 | Why? |
| Peptic Ulcer | 1 | 1964 | 85 | 0.00 | Why? |
| Kidney Calculi | 1 | 1964 | 62 | 0.00 | Why? |
| Prostatic Hyperplasia | 1 | 1964 | 161 | 0.00 | Why? |
| Blood Proteins | 1 | 1964 | 551 | 0.00 | Why? |
| Thyroid Diseases | 1 | 1964 | 285 | 0.00 | Why? |
| Glycoproteins | 1 | 1964 | 615 | 0.00 | Why? |
| Geriatrics | 1 | 1964 | 947 | 0.00 | Why? |
| Liver Cirrhosis | 1 | 1964 | 1810 | 0.00 | Why? |
| Lung Diseases | 1 | 1964 | 2361 | 0.00 | Why? |
| Surgical Procedures, Operative | 1 | 1964 | 2662 | 0.00 | Why? |
| Cardiovascular Diseases | 1 | 1964 | 11497 | 0.00 | Why? |
| Neoplasms | 1 | 1964 | 17251 | 0.00 | Why? |
Pignataro's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(245)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(49)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_